PDF herunterladen
Thromb Haemost 1995; 74(01): 313-321
DOI: 10.1055/s-0038-1642696
Symposium
Molecular Basis of Haemophilias
Schattauer GmbH Stuttgart

Inherited Factor VII Deficiency: Genetics and Molecular Pathology

Authors

  • Edward G D Tuddenham

    Haemostasis Research Group, MRC Clinical Sciences Centre, London, UK

  • Susan Pemberton

    Haemostasis Research Group, MRC Clinical Sciences Centre, London, UK

  • David N Cooper

    Charter Molecular Genetics Laboratory, Thrombosis Research Institute, London, UK
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
09. Juli 2018 (online)

 als PDF herunterladen  Lizenzen und Reprints
Preview Container
 

  • References

  • 1 Meade TW. Factor VII and ischaemic heart disease: epidemiologic evidence. Haemostasis 1983; 13: 178-185
    PubMedSuche in Google Scholar
  • 2 Meade TW, Mellows S, Brozovic M, Miller G J, Chakrabarti RR, North WR S, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the North wick Park Heart Study. Lancet 1986; ii: 533-537
    PubMedSuche in Google Scholar
  • 3 Wion KL, Kelly D, Summerfield JA, Tuddenham EG D, Lawn RM. Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature 1985; 317: 726-729
    CrossrefPubMedSuche in Google Scholar
  • 4 Fair DS. Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Blood 1983; 62: 784-791
    PubMedSuche in Google Scholar
  • 5 Iwanaga S, Nishimura H, Kawabata S, Kisiel W, Hase S, Ikenaka T. A new trisaccharide sugar chain linked to a serine residue in the first EGF-like domain of clotting factors VII and IX and protein Z. Adv. Exp. Med. Biol 1990; 281: 121-131
    PubMedSuche in Google Scholar
  • 6 Bjoem S, Foster DC, Thim L, Wiberg FC, Christensen M, Komiyama Y, Pedersen AH, Kisiel W. Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine J. Biol. Chem 1991; 266: 11051-11057
    PubMedSuche in Google Scholar
  • 7 Thim L, Bjoem S, Christensen M, Nicolai sen EM, Lund-Hansen T, Pedersen AH, Hedner U. Amino acid sequence and posttranslational modifications of human factor Vila from plasma and transfected baby hamster kidney cells. Biochemistry 1988; 27: 7785-7793
    CrossrefPubMedSuche in Google Scholar
  • 8 Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71: 1-8
    PubMedSuche in Google Scholar
  • 9 Wildgoose P, Berkner KL, Kisiel W. Synthesis, purification and characterization of an Argl52-→Gln site directed mutant of recombinant human blood clotting factor VII. Biochemistry 1990; 29: 3413-3420
    CrossrefPubMedSuche in Google Scholar
  • 10 Komiyama Y, Pedersen AH, Kisiel W. Proteolytic activation of human factors IX and X by recombinant human factor Vila: effects of calcium, phospholipids and tissue factor. Biochemistry 1990; 29: 9418-9425
    CrossrefPubMedSuche in Google Scholar
  • 11 Repke K, Gemmell CH, Guha A, Turitto VT, Broze GJ, Nemerson Y. Hemophilia as a defect of the tissue factor pathway of blood coagulation. Effect of factors VIII and IX on factor X activation in a continuous flow reactor Proc. Natl. Acad. Sci. USA 1990; 87: 7623-7627
    CrossrefPubMedSuche in Google Scholar
  • 12 Harlos K, Martin DM A, O’Brien DP, Jones EY, Stuart DI, Polikarpov I, Miller A, Tuddenham EG D, Boys C WG. Crystal structure of the extracellular region of human tissue factor. Nature 1994; 370: 662-666
    CrossrefPubMedSuche in Google Scholar
  • 13 Muller YA, Ultsch MH, Kelley RF, de Vos AM. Structure of the extracellular domain of human tisue factor: location of the factor Vila binding site. Biochemistry 1994; 33: 10864-10870
    CrossrefPubMedSuche in Google Scholar
  • 14 Ruf W, Schullek JR, Stone MJ, Edgington TS. Mutational mapping of functional residues in tissue factor: identification of factor VII recognition determinants in both structural modules of the predicted cytokine receptor homology domain. Biochemistry 1994; 33: 1565-1572
    CrossrefPubMedSuche in Google Scholar
  • 15 Gibbs CS, McCurdy SN, Leung LL K, Paborsky LR. Identification of the factor Vila binding site on tissue factor by homologous loop swap and alanine scanning mutagenesis. Biochemistry 1994; 33: 14003-14010
    CrossrefPubMedSuche in Google Scholar
  • 16 Hagen FS, Gray CL, O’Hara P, Grant FJ, Saari GC, Woodbury RG, Hart CE, Insley M, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA coding for human factor VII. Proc. Natl. Acad. Sci. USA 1986; 83: 2412-2416
    CrossrefPubMedSuche in Google Scholar
  • 17 O’Hara PJ, Grant FJ, Haldeman BA, Gray CL, Insley MY, Hagen FS, Murray MJ. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc. Natl. Acad. Sci. USA 1987; 84: 5158-5162
    CrossrefPubMedSuche in Google Scholar
  • 18 Miao CH, Leytus SP, Chung DW, Davie EW. Liver-specific expression of the gene coding for human factor X, a blood coagulation factor. J. Biol. Chem 1992; 267: 7395-7401
    PubMedSuche in Google Scholar
  • 19 Berkner K, Busby S, Davie E, Hart C, Insley M, Kisiel W, Kumar A, Murray M, O’Hara P, Woodbury R, Hagen F. Isolation and expression of cDNAs encoding human factor VII. Cold Spring Harb. Symp. Quant. Biol 1986; 51: 531-541
    CrossrefPubMedSuche in Google Scholar
  • 20 Brothers AB, Clarke BJ, Sheffield WP, Blajchman MA. Complete nucleotide sequence of the cDNA encoding rabbit coagulation factor VII. Thromb. Res 1993; 69: 231-238
    CrossrefPubMedSuche in Google Scholar
  • 21 Murakawa M, Okamura T, Kamura T, Kuroiwa M, Harada M, Niho Y. Analysis of the partial nucleotide sequences and deuced primary structures of the protease domains of mammalian blood coagulation factors VII and X. Eur. J. Haematol 1994; 52: 162-168
    PubMedSuche in Google Scholar
  • 22 Hassan HJ, Leonardi A, Chelucci C, Mattia G, Macioce G, Guerriero R, Russo G, Mannucci PM, Peschle C. Blood coagulation factors in human embryonic fetal development: preferential expression of the FVII/tissue factor pathway. Blood 1990; 76: 1158-1164
    PubMedSuche in Google Scholar
  • 23 Hassan HJ, Chelucci C, Peschle C, Sorrentino V. Transforming growth factor Binhibits expression of fibrinogen and factor VII in a hepatoma cell line. Thromb. Haemost 1992; 67: 478-483
    Thieme ConnectPubMedSuche in Google Scholar
  • 24 Ragni MV, Lewis JH, Spero JA, Hasiba U. Factor VII deficiency. Am. J. Hematol 1981; 10: 79-88
    CrossrefPubMedSuche in Google Scholar
  • 25 Mariani G, Mazzucconi MG, Hermans J, Ciavarella N, Faiella A, Hassan HJ, Mannucci PM, Nenci GG, Orlando M, Romoli D, Mandelli F. Factor VII deficiency: immunological characterization of genetic variants and detection of carriers. Br. J. Haematol 1981; 48: 7-14
    PubMedSuche in Google Scholar
  • 26 Triplett DA, Brandt JT, Batard MA, Dixon JS, Fair DS. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis. Blood 1985; 66: 1284-1287
    PubMedSuche in Google Scholar
  • 27 Tuddenham EG D, Cooper DN. The Molecular Genetics of Haemostasis and its Inherited Disorders. Oxford University Press, Oxford; 1994
    Suche in Google Scholar
  • 28 Goodnough LT, Saito H, Ratnoff OD. Thrombosis or myocardial infarction in congenital clotting factor abnormalities. Medicine 1983; 62: 248-255
    CrossrefPubMedSuche in Google Scholar
  • 29 Takamiya O, Kemball-Cook G, Martin DM A, Cooper DN, von Felten A, Meili E, Hann I, Prangnell DR, Lumley H, Tuddenham EG D, McVey JH. Detection of missense mutations by single-strand conformational polymorphism (SSCP) analysis in five dysfunctional variants of coagulation factor VII. Hum. Molec. Genet 1993; 2: 1355-1359
    CrossrefPubMedSuche in Google Scholar
  • 30 Cooper DN, Krawczak M. Human Gene Mutation. Bios Scientific, Oxford; 1993
    Suche in Google Scholar
  • 31 Bemardi F, Patracchini P, Gemmati D, Ferrati M, Arcieri P, Papacchini M, Redaelli R, Baudo F, Mariani G, Marchetti G. Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region. Hum. Genet 1993; 92: 446-450
    CrossrefPubMedSuche in Google Scholar
  • 32 Bemardi F, Liney DL, Patracchini P, Gemmati D, Legnani C, Arcieri P, Pinotti M, Redaelli R, Ballerini G, Pemberton S, Wacey AI, Mariani G, Tuddenham EG D, Marchetti G. Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII. Br. J. Haematol 1994; 86: 610-618
    CrossrefPubMedSuche in Google Scholar
  • 33 Marchetti G, Patracchini P, Gemmati D, DeRosa V, Pinotti M, Rodorigo G, Casonato A, Girolami A, Bemardi F. Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7). Hum. Genet 1992; 89: 497-502
    PubMedSuche in Google Scholar
  • 34 O’Brien DP, Gale KM, Anderson JS, McVey JH, Miller GJ, Meade TW, Tuddenham EG D. Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male. Blood 1991; 78: 132-140
    PubMedSuche in Google Scholar
  • 35 Bottema CD K, Ketterling RP, Li S, Yoon H-S, Phillips JA, Sommer SS. Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as “spacer” elements. Am. J. Hum. Genet 1991; 49: 820-838
    PubMedSuche in Google Scholar
  • 36 Wacey AI, Krawczak M, Kakkar VV, Cooper DN. Determinants of the factor IX mutational spectrum in haemophilia B: an analysis of missense mutations using a multi-domain molecular model of the activated protein. Hum. Genet 1994; 94: 594-608
    PubMedSuche in Google Scholar
  • 37 Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries SA. common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscl. Thromb 1991; 11: 540-546
    CrossrefPubMedSuche in Google Scholar
  • 38 Mariani G, Marchetti G, Arcieri P, Bemardi F. The role of factor VII gene polymorphism in determining FVII activity and antigen plasma level. Blood 1994; 84 (01) 86-86 a
    PubMedSuche in Google Scholar
  • 39 Peake I, Thomson J, Poller L, Crowe W, Goodeve A. The factor VII Arg 353 Gin polymorphism as a predictor of high plasma factor VII levels in a normal population. Thromb. Haemost 1993; 69: 624-624
    PubMedSuche in Google Scholar
  • 40 Arbini AA, Bauer KA. Reduced plasma factor VII coagulant activity due to the Arg353Gln polymorphism in the factor VII gene results from defective secretion. Blood 1994; 84 (01) 86-86 a
    PubMedSuche in Google Scholar
  • 41 Arbini AA, Bodkin D, Lopaciuk S, Bauer KA. Molecular analysis of Polish patients with factor VII deficiency. Blood 1994; 84: 2214-2220
    PubMedSuche in Google Scholar
  • 42 Lane A, Cruickshank JK, Mitchell J, Henderson A, Humphries S, Green F. Genetic and environmental determinants of factor VII coagulant activity in different ethnic groups at differing risk of coronary heart disease. Atherosclerosis 1992; 94: 43-50
    CrossrefPubMedSuche in Google Scholar
  • 43 Humphries SE, Lane A, Green F, Cooper J, Miller G. Factor VII coagulant activity and antigen levels in men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscl. Thromb 1994; 14: 193-198
    CrossrefPubMedSuche in Google Scholar
  • 44 Silveira A, Green F, Karpe F, Blomback M, Humphries S, Hamsten A. Elevated levels of factor VII activity in the postprandial state: effect of the factor VII Arg-Gin polymorphism. Thromb. Haemost 1994; 72: 734-739
    Thieme ConnectPubMedSuche in Google Scholar
  • 45 Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briet E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis. Thromb. Haemost 1994; 71: 719-722
    Thieme ConnectPubMedSuche in Google Scholar
  • 46 Giannelli F, Green PM, Sommer SS, Lillicrap DP, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Brownlee GG, Haemophilia B. database of point mutations and short additions and deletions, fifth edition. 1993; Nucleic Acids Res 1994; 22: 3534-3546
    CrossrefPubMedSuche in Google Scholar
  • 47 Kazama Y, Foster DC, Kisiel W. Evidence that an Arg79→Gln substitution in human factor VII is not associated with a reduction in coagulant activity. Blood Coag. Fibrinol 1992; 3: 697-702
    CrossrefPubMedSuche in Google Scholar
  • 48 Chaing S, Clarke B, Sridhara S, Chu K, Friedman P, VanDusen W, Roberts HR, Blajchman M, Monroe DM, High KA. Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor. Blood 1994; 83: 3524-3535
    PubMedSuche in Google Scholar
  • 49 O’Brien DP, Kemball-Cook G, Hutchinson AM, Martin DM A, Johnson DJ D, Byfield PG H, Takamiya O, Tuddenham EG D, McVey JH. Surface plasmon resonance studies of the interaction factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVI molecule (FVII-R79Q) Biochemistry 1994; 33: 14162-14169
    CrossrefPubMedSuche in Google Scholar
  • 50 Reitsma PH, Bemardi F, Doig RG, Gandrille S, Greengard JS, Ireland H, Krawczak M, Lind B, Long GL, Poort SR, Saito H, Sala N, Witt I, Cooper DN. Protein C deficiency: a database of mutations, 1995 update. Thromb. Haemost. 1995 In press
    PubMedSuche in Google Scholar
  • 51 Marchetti G, Ferrati M, Patracchini P, Redaelli R, Bemardi F. A missense mutation (178Cys→Tyr) and two neutral dimorphisms (115His and 333Ser) in the human coagulation factor VII gene. Hum. Molec. Genet 1993; 2: 1055-1056
    CrossrefPubMedSuche in Google Scholar
  • 52 Ohiwa M, Hayashi T, Wada H, Minamikawa K, Shirakawa S, Suzuki K. Factor VII Mie: homozygous asymptomatic type I deficiency caused by an amino acid substitution of His (CAC) for Arg (247) (CGC) in the catalytic domain. Thromb. Haemost 1994; 71: 773-777
    Thieme ConnectPubMedSuche in Google Scholar
  • 53 Bemardi F, Castaman G, Redaelli R, Pinotti M, Lunghi B, Rodeghiero F, Marchetti G. Topologically equivalent mutations causing dysfunctional coagulation factors VII (294Ala→Val) and X (334Ser→Pro). Hum. Molec. Genet 1994; 3: 1175-1177
    CrossrefPubMedSuche in Google Scholar
  • 54 Ruf W. Factor Vila residue Arg290 is required for efficient activation of the macromolecular substrate factor X. Biochemistry 1994; 33: 11631-11636
    CrossrefPubMedSuche in Google Scholar
  • 55 Wildgoose P, Foster D, Schiodt J, Wiberg FC, Biiktoft JJ, Petersen LC. Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII - tissue factor interaction. Biochemistry 1993; 32: 114-119
    CrossrefPubMedSuche in Google Scholar
  • 56 Cunningham BC, Wells JA. Comparison of a structural and functional binding domain in human growth hormone. J Mol Biol 1993; 234: 554-563
    CrossrefPubMedSuche in Google Scholar
  • 57 Kavlie A, Wright MS, Stormorken H, Prydz H. Mutations in the factor VII gene of Norwegian FVII deficient patients. Thromb. Haemost 1993; 69: 612-612
    PubMedSuche in Google Scholar
  • 58 Chen Q, Clarke BJ, Blajchman MA, Ofusu FA. Factor VII Hamilton: a novel type 2 mutation located at residue 57 in the first EGF domain ofhuman factor VII. Thromb. Haemost 1993; 69: 1291-1291
    PubMedSuche in Google Scholar
  • 59 Kuppuswamy MN, Sabharwal AK, Birktoft JJ, Bajaj SP. Molecular characterization of human factor VII Kansas (GK704): substitution of GlnlOO by Arg in one allele and of Arg304 by Gin possibly in the other allele. Thromb. Haemost 1993; 69: 1292-1292
    PubMedSuche in Google Scholar
  • 60 Millar DS, Cooper DN, Kakkar VV, Schwartz M, Scheibel E. Prenatal exclusion of severe factor VII deficiency by DNA sequencing. Lancet 1992; 339: 1359-1359
    PubMedSuche in Google Scholar
  • 61 James HL, Girolami A, Hubbard JG, Kumar A, Fair DS. The dysfunction of coagulation factor VII Padua results from substitution of arginine 304 by glutamine. Biochim. Biophys. Acta 1993; 1172: 301-305
    CrossrefPubMedSuche in Google Scholar
  • 62 Matsushita T, Kojima T, Emi N, Takahashi I, Saito H. Impaired human tissue factor-mediated activity in blood clotting factor VII Nagoya (Arg304→Trp). J. Biol. Chem 1994; 269: 7355-7363
    PubMedSuche in Google Scholar
  • 63 James HL, Zheng D-O, Shurafa M. Factor VII Asp331: a dysfunctional molecule with an amino acid substitution which may interfere with substrate binding. Blood 1994; 84 (01) 61 a
    PubMedSuche in Google Scholar